PT-2023-26043 · Assembly · Trialworks

Charles Heidbreder · Published 2023-07-24 · Updated 2023-07-31 · CVE-2023-37613

Positive Technologies (AI Summary)

CVSS v3.1

6.1

Medium

Base vector

AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Name of the Vulnerable Software and Affected Versions Assembly Software Trialworks version 11.4

Description A cross-site scripting (XSS) issue allows attackers to execute arbitrary web scripts or HTML by injecting a crafted payload into the asset src parameter. This enables the execution of malicious code on the client-side.

Recommendations For Assembly Software Trialworks version 11.4, consider restricting access to the asset src parameter to minimize the risk of exploitation until a patch is available. Avoid using the asset src parameter in sensitive operations until the issue is resolved. At the moment, there is no information about a newer version that contains a fix for this vulnerability.

Exploit

XSS

Weakness Enumeration

CWE-79

Related Identifiers

CVE-2023-37613

Affected Products

Trialworks

References · 5

• 🔥 https://github.com/HeidiSecurities/CVEs/blob/main/Trialworks.md · Exploit
• 🔥 https://github.com/HeidiSecurities/CVEs/blob/main/CVE-2023-37613/Trialworks.md · Exploit
• https://nvd.nist.gov/vuln/detail/CVE-2023-37613 · Security Note
• https://osv.dev/vulnerability/CVE-2023-37613 · Vendor Advisory
• https://t.me/cibsecurity/67181 · Telegram Post